January 07, 2020
11 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Should SLT be the preferred first-line treatment?
NEW YORK — In her presentation at OSN New York 2019, Valerie Trubnik, MD, FACS, discusses results of the LiGHT trial, which compared selective laser trabeculoplasty and eye drop treatment for mild to moderate glaucoma.